GO:0008175 tRNA methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008175 (tRNA methyltransferase activity) describes the catalytic transfer of a methyl group from a donor to a nucleoside residue in a tRNA molecule, either on the nucleobase or the ribose.
• This activity is essential for tRNA maturation, structural stability, and translational fidelity, and it is carried out by enzymes such as METTL1, METTL6, and TRMT10C.
• tRNA methyltransferase activity influences diverse biological processes, including oncogenic transformation, cardiomyocyte maturation, ketogenesis, and osteoblast function.
• Defects in tRNA methyltransferase activity are linked to intellectual disability, cancer, osteoporosis, and mitochondrial dysfunction.
• The catalytic mechanism involves S-adenosylmethionine (SAM) as the methyl donor and specific recognition of tRNA substrates by the methyltransferase domain.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models are powerful tools to dissect the causal roles of tRNA methyltransferases in disease and development.
Description
GO:0008175, tRNA methyltransferase activity, is a molecular function that catalyzes the transfer of a methyl group from a donor to a nucleoside residue within a tRNA molecule. This modification can occur on the nucleobase or the ribose group, and it is critical for the proper maturation and function of tRNA. tRNA methyltransferases are a diverse family of enzymes that ensure translational fidelity and cellular homeostasis, and their dysregulation has been implicated in a wide range of human diseases. Researchers study this activity to understand how post-transcriptional modifications control gene expression and to identify therapeutic targets for cancer, metabolic disorders, and neurological conditions.
tRNA methyltransferase activity At A Glance
| GO ID | GO:0008175 |
|---|---|
| GO term | tRNA methyltransferase activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Catalysis of methyl group transfer to tRNA nucleosides |
| Methyl donor | S-adenosylmethionine (SAM) |
| Target residues | Nucleobase or ribose of tRNA nucleosides |
| Representative enzymes | METTL1, METTL6, TRMT10C |
| Associated diseases | Cancer, intellectual disability, osteoporosis |
What Is GO:0008175?
According to the Gene Ontology, GO:0008175 (tRNA methyltransferase activity) is defined as the catalysis of the transfer of a methyl group from a donor to a nucleoside residue in a tRNA molecule. The methyl group can be transferred to the nucleobase or to the ribose group of the nucleoside. This activity is a molecular function that contributes to tRNA modification and maturation.
Why Is tRNA methyltransferase activity Important in Cell Biology?
tRNA methyltransferase activity is fundamental to translation because methyl modifications influence tRNA stability, codon-anticodon interactions, and ribosome function. Dysregulation of these enzymes can reprogram translation and metabolism, driving diseases such as liver cancer, osteoporotic bone loss, and cardiomyocyte dysfunction. Understanding this activity provides mechanistic insights into gene regulation and offers potential targets for therapeutic intervention.
• Controls translational fidelity and efficiency by modifying tRNA anticodon loops and core regions.
• Regulates metabolic reprogramming, including cholesterol and ketone body metabolism.
• Is essential for mitochondrial tRNA maturation and mitochondrial function.
• Mutations in tRNA methyltransferases cause intellectual disability and neurodevelopmental disorders.
• Drives oncogenic transformation in liver cancer and other malignancies.
• Modulates osteoblast differentiation and bone homeostasis.
• Provides a mechanism for dynamic regulation of gene expression in response to cellular stress.
• Serves as a potential biomarker and therapeutic target in cancer and metabolic diseases.
• Enables structural studies of tRNA-enzyme complexes for drug design.
• Facilitates the development of CRISPR-based disease models to test causality.
What Happens During tRNA methyltransferase activity?
Substrate recognition and binding
In simple terms: The enzyme finds and grabs the correct tRNA molecule.
tRNA methyltransferases specifically recognize their tRNA substrates through structural elements such as the anticodon loop, acceptor stem, or variable loop. For example, METTL6 recognizes tRNA-Ser in complex with seryl-tRNA synthetase, ensuring precise modification. This binding step is critical for selectivity and is often regulated by competing enzyme systems.
Methyl group transfer
In simple terms: The enzyme attaches a methyl group onto a specific spot on the tRNA.
Using S-adenosylmethionine (SAM) as the methyl donor, the enzyme transfers a methyl group to a nucleoside residue, either on the nucleobase (e.g., N1-methyladenosine) or the ribose (e.g., 2'-O-methylation). This modification can alter tRNA structure and function.
tRNA maturation and stability
In simple terms: The methyl mark helps the tRNA fold correctly and survive longer.
Methyl modifications stabilize tRNA tertiary structure and protect against degradation. In mitochondria, TRMT10C-mediated methylation is required for proper tRNA maturation and mitochondrial translation.
Translational regulation
In simple terms: The modified tRNA then helps build proteins more accurately.
Methylated tRNAs influence codon-anticodon pairing and ribosome dynamics, thereby affecting translation of specific mRNAs. METTL1-mediated m7G modification, for instance, promotes translation of genes involved in ketogenesis and cholesterol metabolism.
Key Genes Involved in GO:0008175 tRNA methyltransferase activity
The following genes encode enzymes with tRNA methyltransferase activity or are directly involved in its regulation and function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| METTL1 | Catalyzes N7-methylguanosine (m7G) modification of tRNA | Drives oncogenic transformation and metabolic reprogramming |
| METTL6 | Catalyzes 3-methylcytidine (m3C) modification of tRNA-Ser | Structural basis for tRNA recognition; potential role in translation |
| TRMT10C | Catalyzes N1-methyladenosine (m1A) modification in mitochondrial tRNA | Reverses mitochondrial dysfunction in osteoporosis |
| TRMT1 | Catalyzes N2,N2-dimethylguanosine (m2,2G) in tRNA | Associated with intellectual disability |
| TRMT2A | Catalyzes 5-methyluridine (m5U) in tRNA | Potential role in tRNA stability |
| TRMT5 | Catalyzes N1-methylguanosine (m1G) in tRNA | Linked to mitochondrial function |
| TRMT6 | Component of the TRMT6-TRMT61A complex for m1A modification | Involved in tRNA methylation and cancer |
| TRMT61A | Catalyzes m1A modification in tRNA | Regulates cholesterol metabolism in liver cancer |
| TRMT61B | Mitochondrial m1A methyltransferase | Mitochondrial tRNA modification |
| TRMT10A | Catalyzes m1G in tRNA | Mutations cause intellectual disability and diabetes |
| TRMT11 | Catalyzes 2'-O-methylation in tRNA | Potential role in translation |
| TRMT12 | Catalyzes wybutosine modification in tRNA | Required for translational fidelity |
| TRMT13 | Catalyzes 2'-O-methylation in tRNA | Emerging role in tRNA stability |
| TRMT44 | Catalyzes 2'-O-methylation in tRNA | Associated with neurodevelopmental disorders |
| FTSJ1 | Catalyzes 2'-O-methylation in tRNA | Linked to intellectual disability |
| NSUN2 | Catalyzes 5-methylcytosine (m5C) in tRNA | Regulates tRNA stability and translation |
| DNMT2 | Catalyzes m5C in tRNA | Involved in stress response |
| ALKBH8 | Catalyzes hydroxylation of wybutosine in tRNA | Modulates translation |
How Is tRNA methyltransferase activity Regulated?
tRNA methyltransferase activity is regulated at multiple levels. Competing enzyme systems can modulate the availability of tRNA substrates and the methyl donor SAM. Post-translational modifications and protein-protein interactions, such as the complex between METTL6 and seryl-tRNA synthetase, influence substrate specificity and catalytic efficiency. In mitochondria, TRMT10C activity is coupled to tRNA maturation and mitochondrial function. Additionally, oncogenic signaling can upregulate METTL1 expression, leading to increased m7G modification and enhanced translation of growth-promoting genes.
tRNA methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| METTL1 | Liver cancer, oncogenic transformation | Knockout and overexpression in hepatoma cell lines |
| TRMT10C | Osteoporosis, mitochondrial dysfunction | Knockout in osteoblast precursors |
| TRMT1 | Intellectual disability | Point mutation knock-in in neuronal cells |
| METTL6 | Translation regulation, cancer | Knockout in cancer cell lines |
| FTSJ1 | Intellectual disability | Knockout in neural stem cells |
Cancer and metabolic reprogramming
Dysregulated tRNA methyltransferase activity contributes to tumorigenesis. METTL1-mediated m7G modification drives liver tumourigenesis by regulating cholesterol metabolism. METTL1 also promotes oncogenic transformation through a methyltransferase-independent role in tRNA aminoacylation. These findings highlight tRNA methyltransferases as potential therapeutic targets in cancer.
Intellectual disability and neurodevelopmental disorders
Mutations in tRNA methyltransferase genes, such as TRMT1, TRMT10A, FTSJ1, and TRMT44, are associated with intellectual disability and neurodevelopmental defects. These defects underscore the importance of tRNA modifications for brain development and function.
Mitochondrial dysfunction and osteoporosis
TRMT10C-mediated m1A modification in osteoblasts is critical for mitochondrial function. Targeting this modification reverses mitochondrial dysfunction and ameliorates osteoporosis. Mitochondrial tRNA maturation, which depends on tRNA methyltransferases, is essential for cellular energy metabolism.
Cardiomyocyte maturation and ketogenesis
METTL1 governs ketogenesis through translational regulation and drives metabolic reprogramming during cardiomyocyte maturation. This links tRNA methylation to heart development and metabolic homeostasis.
From tRNA methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of METTL1 affect tRNA methylation and translation? | METTL1 knockout cell lines |
| Can a specific point mutation in TRMT10C rescue mitochondrial function? | Point mutation knock-in in osteoblasts |
| What is the role of METTL6 in tRNA-Ser modification? | Knock-in of tagged METTL6 for structural studies |
| Does overexpression of METTL1 drive oncogenic transformation? | Overexpression in liver cancer cells |
| How does TRMT1 mutation affect neuronal development? | Knockout and point mutation in iPSC-derived neurons |
| Can CRISPR library screening identify synthetic lethal partners of tRNA methyltransferases? | Genome-wide CRISPR knockout library in cancer cells |
How to Study the tRNA methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| m7G-seq | N7-methylguanosine modification sites | Mapping METTL1 targets |
| m1A-seq | N1-methyladenosine modification sites | Mapping TRMT6/61A targets |
| Ribo-seq | Translation efficiency and ribosome occupancy | Studying METTL1-dependent translation |
| Mass spectrometry | Protein interactions and modifications | Identifying METTL6-SerRS complex |
| Cryo-EM | 3D structure of tRNA-enzyme complexes | Structural basis of tRNA recognition |
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Identifying vulnerabilities in cancer |
| qRT-PCR | Gene expression levels | Validating knockout efficiency |
| Western blot | Protein expression and modification | Confirming methyltransferase depletion |
RNA sequencing and modification mapping
RNA-seq and specialized techniques like m7G-seq or m1A-seq can map tRNA modifications and quantify changes in tRNA methyltransferase activity. These methods reveal how modifications affect tRNA stability and translation.
Ribosome profiling (Ribo-seq)
Ribo-seq measures translation efficiency and codon occupancy, providing insights into how tRNA methylation influences protein synthesis. It is particularly useful for studying METTL1-mediated translation of metabolic genes.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify proteins interacting with tRNA methyltransferases and quantify global changes in protein expression. Affinity purification coupled to mass spectrometry reveals complex formation, such as METTL6-SerRS.
Structural biology
Cryo-EM and X-ray crystallography provide atomic-level views of tRNA methyltransferases bound to tRNA and SAM, elucidating catalytic mechanisms and substrate specificity.
How CRISPR Can Be Used to Study GO:0008175 tRNA methyltransferase activity
Knockout
CRISPR knockout of tRNA methyltransferase genes, such as METTL1 or TRMT10C, allows researchers to assess loss-of-function phenotypes in cancer, metabolism, and development. Knockout cell lines are essential for determining whether a gene is required for tRNA modification and downstream processes.
Point Mutation
Introducing specific point mutations in catalytic residues or substrate-binding domains of tRNA methyltransferases can dissect enzymatic activity from non-catalytic functions. For example, point mutations in METTL1 can separate its methyltransferase activity from its role in tRNA aminoacylation.
Knock-in
Knock-in of tagged or mutant versions of tRNA methyltransferases enables precise tracking of protein localization and interaction partners. Tagged knock-in models are valuable for structural and biochemical studies.
Overexpression
Overexpression of tRNA methyltransferases, such as METTL1, can drive oncogenic transformation and metabolic reprogramming, providing models to study gain-of-function effects. Overexpression models are also useful for testing therapeutic inhibitors.
How EDITGENE Supports tRNA methyltransferase activity Research
Researchers studying tRNA methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in disease or development. EDITGENE provides comprehensive CRISPR-based services to generate knockout, point-mutation, knock-in, and overexpression cell models, as well as CRISPR library screening and bioinformatics support, enabling rigorous functional studies of tRNA methyltransferases.
Contact EDITGENE today to design your custom CRISPR model for tRNA methyltransferase activity research.
Frequently Asked Questions About tRNA methyltransferase activity
What is tRNA methyltransferase activity?
tRNA methyltransferase activity (GO:0008175) is the catalysis of methyl group transfer from a donor to a nucleoside residue in a tRNA molecule, either on the nucleobase or the ribose.
What genes are involved in tRNA methyltransferase activity?
Key genes include METTL1, METTL6, TRMT10C, TRMT1, TRMT6, TRMT61A, and FTSJ1, among others.
How does tRNA methyltransferase activity affect translation?
Methyl modifications influence tRNA stability, codon-anticodon pairing, and ribosome function, thereby regulating translation efficiency and fidelity.
What diseases are linked to tRNA methyltransferase defects?
Defects are linked to liver cancer, intellectual disability, osteoporosis, mitochondrial dysfunction, and cardiomyocyte maturation defects.
What is the role of METTL1 in cancer?
METTL1 catalyzes m7G modification on tRNA and drives oncogenic transformation and metabolic reprogramming in liver cancer.
How is tRNA methyltransferase activity regulated?
It is regulated by competing enzymes, substrate availability, protein-protein interactions, and signaling pathways that control enzyme expression.
What methods are used to study tRNA methyltransferase activity?
Common methods include m7G-seq, m1A-seq, Ribo-seq, mass spectrometry, cryo-EM, and CRISPR screening.
Can CRISPR be used to study tRNA methyltransferases?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect their functions.
What is the clinical relevance of TRMT10C?
TRMT10C-mediated m1A modification in osteoblasts is critical for mitochondrial function, and targeting it ameliorates osteoporosis.
How does METTL6 recognize its tRNA substrate?
METTL6 forms a complex with seryl-tRNA synthetase to specifically recognize tRNA-Ser for m3C modification.
Conclusion
tRNA methyltransferase activity (GO:0008175) is a fundamental molecular function that ensures proper tRNA modification and translation. Its dysregulation contributes to cancer, metabolic disorders, and neurodevelopmental diseases. Continued research using CRISPR models and advanced sequencing technologies will uncover new therapeutic opportunities targeting these enzymes.
References
- 1. Ali RH et al.. 2025. A methyltransferase-independent role for METTL1 in tRNA aminoacylation and oncogenic transformation.. Mol Cell 85(5):948-961.e11 PMID: 39892392
- 2. Abedini SS et al.. 2018. tRNA Methyltransferase Defects and Intellectual Disability.. Arch Iran Med 21(10):478-485 PMID: 30415557
- 3. Du T et al.. 2024. The tRNA methyltransferase Mettl1 governs ketogenesis through translational regulation and drives metabolic reprogramming in cardiomyocyte maturation.. Nat Cardiovasc Res 3(12):1438-1453 PMID: 39587264
- 4. Wang Y et al.. 2021. N(1)-methyladenosine methylation in tRNA drives liver tumourigenesis by regulating cholesterol metabolism.. Nat Commun 12(1):6314 PMID: 34728628
- 5. Kerr SJ et al.. 1974. Modulation of tRNA methyltransferase activity by competing enzyme systems.. Adv Enzyme Regul 12:103-17 PMID: 4376890
- 6. Sun H et al.. 2026. Targeting N(1)-methyladenosine modification in osteoblasts through tRNA methyltransferase 10C reverses mitochondrial dysfunction and ameliorates osteoporosis.. Signal Transduct Target Ther 11(1) PMID: 42310289
- 7. Meynier V et al.. 2024. Structural basis for human mitochondrial tRNA maturation.. Nat Commun 15(1):4683 PMID: 38824131
- 8. Throll P et al.. 2024. Structural basis of tRNA recognition by the m(3)C RNA methyltransferase METTL6 in complex with SerRS seryl-tRNA synthetase.. Nat Struct Mol Biol 31(10):1614-1624 PMID: 38918637
